These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 8901994)

  • 1. Muscle relaxants: a clinical update.
    Buzello W; Diefenbach C; Nigrovic V
    Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New muscle relaxants].
    Diefenbach C; Buzello W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):2-8. PubMed ID: 8868525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 4. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.
    Kansanaho M; Olkkola KT
    Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurarization during retransfusion of autologous blood withdrawn after injection of muscle relaxants: a comparison of rocuronium and mivacurium.
    Rohling RG; Rentsch KM; Beck-Schimmer B; Fuchs-Buder T
    J Clin Anesth; 2003 Mar; 15(2):85-90. PubMed ID: 12719045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle relaxants in paediatric day case surgery.
    Meakin GH
    Eur J Anaesthesiol Suppl; 2001; 23():47-52. PubMed ID: 11766247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New skeletal muscle relaxants.
    Caldwell JE
    Int Anesthesiol Clin; 1995; 33(1):39-60. PubMed ID: 7635557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on newer neuromuscular blocking drugs.
    Holm H; Ostergaard D
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of action of mivacurium is prolonged if preceded by atracurium or vecuronium.
    Rautoma P; Meretoja OA; Erkola O; Kalli I
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):912-5. PubMed ID: 8848891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming rapacuronium: a comparison with rocuronium and mivacurium.
    Steinberg D
    Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
    Stout RG; Shine TS; Silverman DG; Brull SJ
    Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mivacurium chloride--a comparative profile.
    Diffenbach C; Buzello W; Mellinghoff H
    Acta Anaesthesiol Scand Suppl; 1995; 106():23-5. PubMed ID: 8533540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.